ARTICLE
12 November 2020

Patent Strategy In The Life Sciences Industry

FH
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Contributor

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP is a law firm dedicated to advancing ideas, discoveries, and innovations that drive businesses around the world. From offices in the United States, Europe, and Asia, Finnegan works with leading innovators to protect, advocate, and leverage their most important intellectual property (IP) assets.
In this podcast, Finnegan partners John Livingstone and Naoki Yoshida are joined by Rob Gorman, Senior Vice President and Assistant General Counsel for Bausch Health...
United States Intellectual Property

In this podcast, Finnegan partners John Livingstone and Naoki Yoshida are joined by Rob Gorman, Senior Vice President and Assistant General Counsel for Bausch Health, to discuss Kaken v. Iancu—the case that led the firm to receive the "Patent Impact Case of the Year" and "Patent Strategy Firm of the Year" awards at the 2020 LMG Life Sciences Awardsand how the case highlights the firm's efforts to align itself with client goals to achieve results. In addition, John and Naoki discuss how Finnegan trains and develops its IP attorneys, and how an IP-driven portfolio must be aligned with business perspectives. The discussion also covers life sciences in the age of coronavirus. 

1005358.jpg

To listen to the podcast, please click here

Originally Published by Finnegan, November 2020

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More